How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 13, Issue 12, Pages 1749-1762
Publisher
Informa Healthcare
Online
2014-09-22
DOI
10.1517/14740338.2014.959489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammatory Bowel Disease and Pregnancy: Evidence, Uncertainty and Patient Decision-Making
- (2016) Flavio M Habal et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
- (2013) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease
- (2013) M J Casanova et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
- (2012) Maria Chaparro et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Management of inflammatory bowel disease in pregnancy
- (2012) Séverine Vermeire et al. Journal of Crohns & Colitis
- P370 Pregnancy and newborn outcome of mothers with inflammatory bowel disease exposed to anti-TNFα therapy during pregnancy: Three-centre study
- (2012) N. Machkova et al. Journal of Crohns & Colitis
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- (2012) David Laharie et al. LANCET
- High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy
- (2011) Z. Zelinkova et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- TNF-α and the Development of the Neonatal Immune System: Implications for Inhibitor Use in Pregnancy
- (2011) Razvan Arsenescu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy
- (2011) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies
- (2011) Walter Reinisch et al. INFLAMMATORY BOWEL DISEASES
- Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis
- (2011) Annalisa Aratari et al. Journal of Crohns & Colitis
- Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease
- (2011) Shomron Ben-Horin et al. Journal of Crohns & Colitis
- Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31
- (2011) Casper Steenholdt et al. Journal of Crohns & Colitis
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
- (2010) Uma Mahadevan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature
- (2010) Lucianna Motta Correia et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- European evidenced-based consensus on reproduction in inflammatory bowel disease
- (2010) C. Janneke van der Woude et al. Journal of Crohns & Colitis
- An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies
- (2009) Nele Pentšuk et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- A 24-Year-Old Pregnant Woman With Inflammatory Bowel Disease
- (2009) Jason K. Hou et al. Clinical Gastroenterology and Hepatology
- Adalimumab Level in Breast Milk of a Nursing Mother
- (2009) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding
- (2009) Javier P. Gisbert INFLAMMATORY BOWEL DISEASES
- Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohnʼs Disease Before and After Delivery
- (2009) Sunanda Kane et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
- (2009) Gert Van Assche et al. Journal of Crohns & Colitis
- 499 The Effect of Maternal Peripartum Infliximab Use On Neonatal Immune Response
- (2008) Uma Mahadevan et al. GASTROENTEROLOGY
- Management of inflammatory bowel disease in the pregnant patient
- (2008) Flavio M Habal et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Is infliximab safe to use while breastfeeding?
- (2008) Joel Z Stengel et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Safe use of infliximab for the treatment of fistulizing Crohnʼs disease during pregnancy within 3 months of conception
- (2007) Erika Angelucci et al. INFLAMMATORY BOWEL DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started